Paper Details

  1. Home
  2. Paper Details

[Takotsubo cardiomyopathy developing during anagrelide therapy in a patient with essential thrombocythemia].

Author: HaradaShinpei, KimuraHiroyuki, NagashimaTakahiro

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Case ReportsIn the medical field, a report that describes in detail a unique case, an unusual medical condition, or the effect of a treatment. Provides new insights and possibilities for treatment through individual patient cases.

Overview

Takotsubo cardiomyopathy (Tako) is a heart condition that mimics a heart attack but is not caused by blocked coronary arteries. This case report describes a 76-year-old woman taking anagrelide for essential thrombocythemia who developed Tako. While Tako is usually attributed to stress, the only potential stressor in this case was the anagrelide therapy. The report highlights the importance of considering Tako as a possible side effect of anagrelide therapy.
Paper Details　
Original Abstract of the Article :
A 76-year-old woman taking anagrelide (ANA) for essential thrombocythemia (ET) was rushed to the hospital by ambulance because of severe chest pain. Echocardiography revealed apical akinesis with basal and mid-hyperkinesis, and a coronary angiography revealed no significant stenosis in the dominant ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.11406/rinketsu.59.2606

データ提供：米国国立医学図書館（NLM）

Takotsubo Cardiomyopathy: A Sandstorm in the Heart

The heart, like a desert oasis, can be a fragile and vulnerable organ. This case report highlights the sudden and unexpected appearance of takotsubo cardiomyopathy (Tako) during anagrelide therapy for essential thrombocythemia. This unexpected sandstorm in the heart serves as a reminder of the potential complications that can arise during medical treatment.

Navigating the Landscape of Anagrelide Therapy: A Journey with Potential Hazards

Anagrelide, a drug used to treat essential thrombocythemia, is known to have potential cardiovascular effects. This case report highlights the risk of developing Tako during anagrelide therapy. This finding underscores the importance of careful monitoring and awareness of potential complications when treating patients with anagrelide.

A Cautionary Tale: The Desert Can Be Unpredictable

This case serves as a reminder that even seemingly safe medical treatments can have unexpected consequences. It highlights the importance of vigilance and careful monitoring in the treatment of complex conditions like essential thrombocythemia.

Dr. Camel’s Conclusion

This case report emphasizes the potential risks associated with anagrelide therapy, particularly the unexpected appearance of takotsubo cardiomyopathy. Just as the desert landscape can be unpredictable, the human body can react in unexpected ways to medical interventions. It underscores the importance of vigilant monitoring and a comprehensive understanding of potential complications during medical treatment.

Date :
  1. Date Completed 2019-07-02
  2. Date Revised 2019-07-02
Further Info :

Pubmed ID

30626797

DOI: Digital Object Identifier

10.11406/rinketsu.59.2606

Related Literature

Article Analysis
・Effects of anagrelide
SNS
PICO Info
in preparation
Languages

Japanese

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.